TotalMarketCap

Zevra Therapeutics

ZVRANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$626.584 M

$10.53 -5.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Zevra Therapeutics (ZVRA) has a market capitalization of $626.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$83.2M

#1366 by earnings

Shares outstanding

59,504,621

Latest filing cover page

P/E ratio

7.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #166Sagimet BiosciencesSGMT$642.6M
  2. #167Wave Life SciencesWVE$638.0M
  3. #168Zevra TherapeuticsZVRA$626.6M
  4. #169Evotec SEEVO$626.1M
  5. #170Design TherapeuticsDSGN$624.4M

What if Zevra Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$474,532.45

Per share 45,065× higher

Bitcoin $1.53T

$25,676.12

Per share 2,438× higher

Apple $5.02T

$84,292.32

Per share 8,005× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Zevra Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.